CB Scientific, Inc. (CBSC)
USD 0.04
(-11.11%)
USD 0.04
(-11.11%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -1.62 Million USD | 24.06% |
| 2022 | -2.1 Million USD | -12.36% |
| 2021 | -4.79 Million USD | 36.3% |
| 2020 | -3.97 Million USD | -193.75% |
| 2019 | -999.45 Thousand USD | -1578.34% |
| 2018 | -59.54 Thousand USD | 87.54% |
| 2017 | -1.12 Million USD | -29.46% |
| 2016 | -369.28 Thousand USD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -264.06 Thousand USD | 20.34% |
| 2023 Q4 | -331.48 Thousand USD | 31.6% |
| 2023 Q3 | -484.64 Thousand USD | -5.2% |
| 2023 Q1 | -318.88 Thousand USD | 61.0% |
| 2023 Q2 | -460.69 Thousand USD | -44.47% |
| 2023 FY | - USD | 24.06% |
| 2022 Q2 | -420.64 Thousand USD | 4.37% |
| 2022 FY | - USD | -12.36% |
| 2022 Q4 | -817.67 Thousand USD | -93.22% |
| 2022 Q3 | -423.18 Thousand USD | -0.6% |
| 2022 Q1 | -439.87 Thousand USD | -123.2% |
| 2021 Q3 | -3.35 Million USD | -1725.93% |
| 2021 Q1 | -217.97 Thousand USD | 88.23% |
| 2021 Q2 | -183.96 Thousand USD | 15.6% |
| 2021 Q4 | 1.89 Million USD | 156.44% |
| 2021 FY | - USD | 36.3% |
| 2020 FY | - USD | -193.75% |
| 2020 Q4 | -1.85 Million USD | 0.0% |
| 2019 FY | - USD | -1578.34% |
| 2018 FY | - USD | 87.54% |
| 2017 Q4 | -505.16 USD | 0.0% |
| 2017 FY | - USD | -29.46% |
| 2016 FY | - USD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| American Medical Technologies Inc. | -963.95 Thousand USD | -68.571% |
| Ansell Limited | 209.86 Million USD | 100.774% |
| Ansell Limited | 206.3 Million USD | 100.788% |
| BG Medicine, Inc. | - USD | Infinity% |
| Biotage AB (publ) | 42.83 Million USD | 103.793% |
| BioLife Sciences Inc. | - USD | Infinity% |
| Psykey, Inc. | -1.29 Million USD | -25.449% |
| ConvaTec Group Plc | 455.5 Million USD | 100.357% |
| ConvaTec Group Plc | 455.5 Million USD | 100.357% |
| Encision Inc. | -544.19 Thousand USD | -198.597% |
| Golden Valley Development, Inc | -141.81 Thousand USD | -1045.865% |
| Hear AtLast Holdings, Inc. | -109.93 Thousand USD | -1378.169% |
| Innovative MedTech Inc. | -7.67 Million USD | 78.825% |
| LifePoint, Inc. | -14.2 Million USD | 88.558% |
| Medite Cancer Diagnostics, Inc. | -6.18 Million USD | 73.736% |
| Paradigm Medical Industries, Inc. | -325 Thousand USD | -399.985% |
| QuantRx Biomedical Corporation | - USD | Infinity% |
| Remedent, Inc. | -215.23 Thousand USD | -654.969% |
| Reflect Scientific, Inc. | -405.78 Thousand USD | -300.447% |
| SmileDirectClub, Inc. | -186.13 Million USD | 99.127% |
| Sector 10, Inc. | - USD | Infinity% |
| Shandong Weigao Group Medical Polymer Company Limited | 447.82 Million USD | 100.363% |
| SheerVision, Inc. | -110.53 Thousand USD | -1370.131% |
| United Health Products, Inc. | -2.5 Million USD | 35.059% |
| Vasamed, Inc. | -4.57 Million USD | 64.478% |
| Wearable Health Solutions, Inc. | -2.26 Million USD | 28.123% |
| Yubo International Biotech Limited | -1.17 Million USD | -37.978% |